Your browser doesn't support javascript.
loading
Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic Response.
Conery, Andrew R; Centore, Richard C; Spillane, Kerry L; Follmer, Nicole E; Bommi-Reddy, Archana; Hatton, Charlie; Bryant, Barbara M; Greninger, Patricia; Amzallag, Arnaud; Benes, Cyril H; Mertz, Jennifer A; Sims, Robert J.
Afiliação
  • Conery AR; Constellation Pharmaceuticals, Inc., Cambridge, Massachusetts.
  • Centore RC; Constellation Pharmaceuticals, Inc., Cambridge, Massachusetts.
  • Spillane KL; Constellation Pharmaceuticals, Inc., Cambridge, Massachusetts.
  • Follmer NE; Constellation Pharmaceuticals, Inc., Cambridge, Massachusetts.
  • Bommi-Reddy A; Constellation Pharmaceuticals, Inc., Cambridge, Massachusetts.
  • Hatton C; Constellation Pharmaceuticals, Inc., Cambridge, Massachusetts.
  • Bryant BM; Constellation Pharmaceuticals, Inc., Cambridge, Massachusetts.
  • Greninger P; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Amzallag A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Benes CH; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Mertz JA; Constellation Pharmaceuticals, Inc., Cambridge, Massachusetts.
  • Sims RJ; Constellation Pharmaceuticals, Inc., Cambridge, Massachusetts. robert.Sims@constellationpharma.com.
Cancer Res ; 76(6): 1313-9, 2016 Mar 15.
Article em En | MEDLINE | ID: mdl-26759243

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Apoptose / Bibliotecas de Moléculas Pequenas / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Res Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Apoptose / Bibliotecas de Moléculas Pequenas / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Res Ano de publicação: 2016 Tipo de documento: Article